Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Glycemia Risk Index Measures Hypoglycemia, Hyperglycemia Risk in Patients With T1D
February 17th 2023The glycemia risk index (GRI) showed that pediatric patients and those receiving continuous subcutaneous insulin infusion had higher overall component of hypoglycemia than adults and those receiving multiple doses of insulin.
Read More
Dr Daniel Weiner: We Need to Better Prioritize Early Detection, Preventive Care for DKD
February 16th 2023While there are a number of treatments available for diabetic kidney disease (DKD), the biggest limitation is the lack of early detection, said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.
Read More
Nearly Identical Rates of Overweight, Obesity Between Adults With T1D, General Population
February 14th 2023Data showed that 64% of adults without any type of diabetes had overweight or obesity, compared with 62% of adults with type 1 diabetes (T1D) and 86% with type 2 diabetes between 2016 and 2021.
Read More
Dr Mary Cushman: Has an "Awakening of Consciousness" Improved Certain Treatment Disparities?
February 11th 2023Mary Cushman, MD, professor of medicine at the University of Vermont, and director of the thrombosis and hemostasis program at the University of Vermont Medical Center, talks about racial disparities in pulmonary embolism treatment.
Read More
Family-Centered Interventions Improve Health Outcomes in Children, Adolescents With T1D
February 11th 2023Interventions in 9 studies were linked with varying effects on glycated hemoglobin, type 1 diabetes (T1D) management adherence, self-management behaviors, and parent-child teamwork in T1D management.
Read More
Dr Jeremy Abramson Discusses CAR T-Cell Therapy Timing in DLBCL
February 4th 2023Jeremy Abramson, MD, director of the Jon and Jo Ann Hagler Center for Lymphoma at the Massachusetts General Hospital Cancer Center, shared his take on the potential benefits of chimeric antigen receptor (CAR) T-cell therapy in earlier lines of treatment.
Read More